Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has leased laboratory space (the “NanoShrink Lab”) inside the TechPortal, an innovative and brand new technology facilitator center for commercial bioscience research companies which are in most cases based on University of California, Irvine research.
“As Shrink gets ready to launch its first commercial products, NanoShrink and the StemDisc family of products, Shrink has decided to adopt a unique development and product marketing and distribution plan, especially for our NanoShrink product,” stated Mark L. Baum, CEO of Shrink. “NanoShrink is a product that has so many applications, and our goal is to demonstrate (with robust and rich audio and video content) how we believe this product can make a difference – in areas as diverse as printed electronics to microfluidics and diagnostics sensor prototyping. We believe that the best way to highlight these 'apps' is to open an office, and do the app development internally, alongside commercial users – once the product is launched – and to use an integrated web platform to actually show how the product can save innovators worldwide, time, money and at the same time give them increased performance and design flexibility. We will do this for NanoShrink as well as StemDisc.
“The NanoShrink Lab is a world class space located within UCI, a world class university. For a small company like Shrink to have access to 'downstream' resources as part of UCI's broader intellectual community of published researchers, leading bioscientists, businesspeople at the TechPortal and the amazing UCI people and facilities, not to mention our scientific founder – this is nearly unprecedented for a public company such as ours. We are certainly pleased to be a part of the TechPortal and we look forward to using our time there to launch products and develop a new technology that adds value for our shareholders and which makes a difference in the lives of researchers and scientists who are searching for ways to make all of our lives healthier and more productive, the world over.”